Cargando…
A rare case of acute promyelocytic leukemia with IRF2BP2-RARA fusion; and literature review
BACKGROUND: Acute promyelocytic leukemia (APL) is commonly characterized by the fusion of retinoic acid receptor alpha (RARA) with promyelocytic leukemia (PML). Most APL patients acquire long-term survival after treatment with all-trans retinoic acid (ATRA) or arsenic agents-based chemotherapy. CASE...
Autores principales: | Liu, Yiping, Xu, Fang, Hu, Hong, Wen, Jingjing, Su, Jing, Zhou, Qiaolin, Qu, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684484/ https://www.ncbi.nlm.nih.gov/pubmed/31447564 http://dx.doi.org/10.2147/OTT.S217622 |
Ejemplares similares
-
New variant of acute promyelocytic leukemia with IRF2BP2–RARA fusion
por: Shimomura, Yoshimitsu, et al.
Publicado: (2016) -
Educational Case: Acute Promyelocytic Leukemia With
PML-RARA
por: Kunak, Rebecca L., et al.
Publicado: (2019) -
HNRNPC-RARA Fusion Gene in a Case with Acute Promyelocytic Leukemia Lacking PML-RARA Rearrangement Presenting with Abundant Hemophagocytosis
por: Tan, Jing, et al.
Publicado: (2023) -
Case report: Identification of a novel HNRNPC::RARG fusion in acute promyelocytic leukemia lacking RARA rearrangement
por: Ding, Wenjing, et al.
Publicado: (2023) -
Cytogenetically cryptic PML::RARA fusion in acute promyelocytic leukemia: Testing strategies in the modern era
por: Karlin, Kirill, et al.
Publicado: (2022)